Scientific Work
We develop innovative approaches and technologies for image-based, quantitative medical tests. In doing so, we manage the entire development cycle—from scientific ideas through software development, mechanical product design, production, and market launch.
Publications:
June 2023 - EAACI 2023
Assessment of allergy immunotherapy efficiency by quantification of conjunctival provocation tests with Artificial Intelligence based tool “AllergoEye”.
European Academy of Allergy and Clinical Immunology (EAACI) Congress 1st–3rd July 2023 9 - 11 June Hamburg, Germany 2023, Flash talks (FT). Allergy, 78: 3-166.
https://doi.org/10.1111/all.15923
May 2023
Yarin Y, Kalaitzidou A, Bodrova K, Mösges R, Kalaidzidi Y.:
Validation of AI-based software for objectification of conjunctival provocation test.
Journal of Allergy and Clinical Immunology: Global. Epub 2023 May 29.
https://doi.org/10.1016/j.jacig.2023.100121
August 2022
Validation for Artificial Intelligence in Provocation Tests.
Review of the European Academy of Allergy and Clinical Immunology (EAACI) Congress 1st–3rd July 2022, Prague, Czechia, Congress Highlights. EMJ (European Medical Journal) Allergy & Immunology, August 2022, Page 15, DOI/10.33590/emjallergyimmunol/.
https://doi.org/10.33590/emjallergyimmunol/10152128
July 2022
Clinical validation of “AllergoEye”—An Artificial Intelligence based platform for quantification of conjunctival provocation tests
Kalaitzidou A., Bodrova K ., Kalaitzidis I., Yarin Y.Allergy (European journal of the Academy of Allergy and Clinical Immunology). Special Issue: Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1‐3 July 2022, Volume 78, Issue S111, February 2023, Pages 28,
https://doi.org/10.1111/all.15614
November 2021
“AllergoEye” - Fully automatic quantitative conjunctival provocation test based on Artificial Intelligence.
Kalaitzidou A., Yarin, Y.Kalaitzidis I. Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 10-12 July 2021. Allergy. 2021 Nov;76 Suppl 110:5-661. doi: 10.1111/all.15093. PMID: 34783029.